iqvia weight loss drug prescriptions q3 2024 semaglutide tirzepatide The weight-loss boom has created massive market opportunities — and punishing failures. In this space, a single clinical trial result can send a stock soaring or instantly wipe out years of gains iqvia weight loss drug prescriptions

The first head-to-head clinical trial (SURMOUNT-5, published in NEJM 2025) showed tirzepatide produced 20.2% average weight loss at 72 weeks versus 13.7% for semaglutide approximately 47% greater relative weight loss

These results help PlexusDx and your provider personalize your tirzepatide dose, exercise recommendations, and nutrition plan so you build muscle and lose fat efficiently

POSSIBLE SIDE EFFECTS AND SAFETY INFORMATION

Be sure to follow the instruction guide for each weekly dose

La mesoterapia corporal es un tratamiento de medicina esttica que, gracias a la infiltracin de un cctel de medicamentos y principios activos (en el caso de la grasa localizada, normalmente compuesto por lipolticos como la fosfatidilcolina y la L-carnitina), consigue eliminar los depsitos grasos localizados

When people feel better and have more energy, they are more likely to stay active and stick to healthy eating habits